High Priority HIV and Substance Use Research (RM1 Clinical Trial Optional)

National Institutes of Health
Award USD 0–1.5M ≈ €0–€1.4M
Closing date 339 days left · Mar 05, 2027
Location Global
For Individuals, Team, Orgs

About this opportunity

This funding opportunity announcement supports high priority research at the intersection of HIV and substance use. The program invites innovative research projects with the potential to open new areas of HIV/AIDS research and/or lead to new avenues for prevention, treatment and cure of HIV among people who use drugs (PWUD). Applications are required to have a detailed research plan, preliminary data, and a clear description of the nexus with substance use. The FOA is open to both individual researchers and research teams and includes all areas of research from basic science to clinical and implementation research. All studies must focus on NIH HIV/AIDS Research Priorities as outlined in NOT-OD-20-018: UPDATE: NIH HIV/AIDS Research Priorities and Guidelines for Determining HIV/AIDS Funding.

Who can apply

Applicant Types

individual, team, organization

Organization Types

nonprofit, for profit, academic, government, tribal

Residency

🇺🇸 United States

Project Locations

🇺🇸 United States

Region

United States

How to apply

Stages

  1. 1 single_stage

Required documents

research_proposal · budget

External listing — not managed by a verified Grantory funder

External Application

This opportunity requires you to apply directly on the funder's website.

Apply on External Site

AI-Extracted Data

This opportunity was automatically extracted from an external source using AI. Details such as amounts, closing dates, and eligibility may be incomplete or inaccurate.

Always verify on the official source